IMAGION TEAMS WITH SIEMENS HEALTHINEERS

This is huge and significantly de risks there MagSense nanoparticals as an MRI contrast agent. The collaboration will see Siemens Healthineers work with IMAGION to identify optimal MRI scanning protocols for MagSense. IMAGION has received "Breakthrough" device designation from US food and drug administration.

The potential here is absolutely enormous and I advise any new investors to do your own research.

Siemens have over 120 years of experience in this field, I can comfortably now say we have the right people on our side making this a huge success in the making. There has never been a better time than now to be onboard this exciting stock the wheels are starting to turn.

Good luck and DYOR.